Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Perinatol ; 33(8): 800-7, 2016 07.
Article in English | MEDLINE | ID: mdl-26906181

ABSTRACT

Objective This study aims to determine whether nasopharyngeal (NP) colonization with group B streptococcus (GBS) is associated with early-onset clinical sepsis within 72 hours of birth, prolonged antibiotic duration, longer neonatal intensive care unit (NICU) stay, and delay in tolerating full feeds among neonates ≥ 35 weeks gestation. Study Design A retrospective cohort study of 192 NICU neonates admitted for sepsis evaluation. Based on their GBS colonization status, the mother-neonate pairs were divided into four groups of mother-negative neonate (baby)-positive (MNBP), mother-positive neonate-positive (MPBP), mother-positive neonate-negative (MPBN), and a reference group of mother-negative neonate-negative (MNBN). Neonates with GBS-positive blood cultures were excluded. Results The colonized neonate groups of MNBP (odds ratio [OR]: 21.8, 95% confidence interval [CI]: 7.99, 59.44) and MPBP (OR: 35.5, 95% CI: 9.57, 131.70) were each associated with increased odds for clinical sepsis (p < 0.001). A similar pattern occurred for prolonged antibiotic use. MPBP group was associated with the increased NICU stay (adjusted ß: 0.1, standard error = 0.05, p < 0.01). None of the GBS groups were associated with increased days to full feeds. Conclusion Neonatal NP GBS colonization was found among a substantial proportion of GBS-negative mothers and was associated with an increased diagnosis of clinical sepsis.


Subject(s)
Mother-Child Relations , Neonatal Sepsis/diagnosis , Streptococcal Infections/diagnosis , Streptococcus agalactiae/isolation & purification , Adult , Anti-Bacterial Agents/therapeutic use , Female , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Length of Stay , Linear Models , Logistic Models , Male , Nasopharynx/microbiology , Neonatal Screening , Neonatal Sepsis/microbiology , New York , Odds Ratio , Retrospective Studies , Streptococcal Infections/drug therapy
2.
Pediatr Rev ; 35(10): e49-52, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25274976

ABSTRACT

ACC is a rare condition that has to be approached by a multidisciplinary team, including a pediatrician, dermatologist, and plastic surgeon. Associated malformations should be ruled out in a patient with ACC, and conservative management is usually the mainstay of treatment. Antibiotic therapy is not used routinely unless lesions are infected.


Subject(s)
Ectodermal Dysplasia/diagnosis , Ectodermal Dysplasia/classification , Female , Humans , Infant, Newborn , Lower Extremity
SELECTION OF CITATIONS
SEARCH DETAIL
...